Popular Keywords
Psycho-oncology
Surgical Oncology
Oncopathology
Gynecologic Oncology
Computational Oncology
Head and Neck Oncology
Correspondence to Author: Sathya Narayan,
Department of Radiation Oncology, S.P. Medical College and Associated Group of Hospital, India.
Abstract:
Seldom is there research for the pediatric age range describing
the correlation between acute lymphoblastic leukemia
(ALL) and systemic lupus erythematosus (SLE). Typically,
lymphoproliferative illness develops after SLE, although The
cancer may develop sooner or even at the same time. We
present the case of a 15-year-old boy youngster who was
diagnosed with SLE 12 years ago and was unintentionally
diagnosed with ALL during a regular investigation.
SLE is an inflammatory illness that affects multiple systems
and is characterized by inflammation of the connective tissue
and blood vessels. There is great variation in the clinical
symptoms. 10% to 20% of patients are thought to have been
diagnosed with SLE before reaching adulthood. Even in the
prepubescent age range, girls are more likely than boys to
experience childhood SLE (8:1). Typically, childhood SLE is
more severe.
Compared to adult SLE, SLE is typically more severe and has
a worse prognosis. Antinuclear antibodies are a defining
feature of sickle cell disease (SLE). There are very few
cases of juvenile children with SLE and acute lymphoblastic
leukemia (ALL) documented in the literature. Although the
neoplasia can develop earlier or even concurrently with
lymphoproliferative illness, SLE typically occurs before the
latter.
Introduction: A complete blood count revealed elevated TLC in a 15-year-old
male boy who was a known case of lupus nephritis during a
routine follow-up. Acute lymphoblastic leukemia is suggested
by peripheral blood film analysis (Figure 1. 60% of the blasts
identified by flow cytometry analysis were positive for CD79a+,
CD45+, CD34+, HLADR+, CD20+, CD38+, CD19+, CD10+, and
CD22 HTG +, whereas CD13,33,3, and MPO were negative.
Fluocytometry points to acute lymphoblastic leukemia in B
cells. The child’s karyotype was 46XY, and no hypo- nor hyperdiploidy was observed (Figure 2). In all the metaphases, the
Philadelphia chromosome was not visible. No indication of
t(15:17), t(8:21), or inversion 16 was found. At five years old,
the sibling was likewise diagnosed with ALL. A youngster
developed twelve years ago.
The results of the clinical assessment were negative. Following
a kidney biopsy, the glomeruli exhibit mesenchymal growth
along with an increase in segmental mesenchymal cellularity.
thickening of the basement membrane. Medially, blood
vessels exhibit a slight thickening. Focal space inflammatory
infiltration is visible in the interstitial.
The glomeruli did not exhibit crescent development, tuft
necrosis, segmental or widespread proliferation. The histology
that has been discussed points to lupus nephitis (WHO class II).
Both anti-double stranded DNA (anti-dsDNA) and anti-nuclear
antibody (ANA) tested positive. The patient had been taking
prednisone for SLE from the beginning, but six months ago the
medication was discontinued due to illness considerations.
Keywords :
Systemic lupus erythematosus; Acute lymphoblastic
leukemia; Anti-double stranded DNA.
Citation:
Sathya Narayan. A Male Child’s Coexistence of Lupus Erythematosus and Acute Lymphoblastic Leukemia: An Extremely Rare Association. The Journal of Clinical Oncology 2024.
Journal Info
- Journal Name: The Journal of Clinical Oncology
- Impact Factor: 2.305*
- ISSN: 3064-7002
- DOI: 10.52338/tjoco
- Short Name: TJOCO
- Acceptance rate: 55%
- Volume: 7 (2024)
- Submission to acceptance: 25 days
- Acceptance to publication: 10 days
OUR PUBLICATION BENEFITS
- International Reach
- Peer Review
- Rapid Publication
- Open Access
- High Visibility